Amrize (NYSE:AMRZ) Stock Price Target Lowered at JPMorgan Chase & Co.

Amrize (NYSE:AMRZ) had its price objective reduced by equities research analysts at JPMorgan Chase & Co. from $52.00 to $48.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 31.87% from the company’s current price.

A number of other analysts also recently issued reports on AMRZ. Zacks Research downgraded Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Stephens cut their price objective on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. Citigroup decreased their price objective on shares of Amrize from $58.00 to $50.00 and set a “buy” rating on the stock in a research report on Friday, October 2nd. Sanford C. Bernstein restated an “outperform” rating and issued a $60.00 price objective on shares of Amrize in a research report on Monday, September 21st. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research note on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $50.00.

Amrize Price Performance

Shares of AMRZ stock traded up $0.31 on Tuesday, reaching $36.40. The company’s stock had a trading volume of 1,823,987 shares, compared to its average volume of 3,354,850. The company has a market capitalization of $20.13 billion, a P/E ratio of 16.78, a PEG ratio of 1.27 and a beta of 0.20. Amrize has a 12-month low of $35.78 and a 12-month high of $65.94. The stock’s 50 day simple moving average is $42.03 and its 200-day simple moving average is $49.30. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ) last posted its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. As a group, equities analysts predict that Amrize will post 2.46 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Baris Oran bought 3,000 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average price of $47.38 per share, with a total value of $142,140.00. Following the completion of the purchase, the chief financial officer directly owned 3,000 shares in the company, valued at $142,140. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Mario Gross purchased 3,568 shares of the stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the transaction, the insider directly owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. This represents a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 48,983 shares of company stock valued at $2,158,755 in the last three months. 0.54% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Amrize

Several institutional investors have recently modified their holdings of AMRZ. Pictet Asset Management Holding SA lifted its position in Amrize by 4.7% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock worth $283,017,000 after buying an additional 234,731 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after buying an additional 171,622 shares in the last quarter. First Manhattan CO. LLC. boosted its stake in Amrize by 20.0% in the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock worth $218,305,000 after buying an additional 672,030 shares in the last quarter. River Road Asset Management LLC boosted its stake in Amrize by 26.1% in the fourth quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company’s stock worth $155,942,000 after buying an additional 597,542 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock worth $109,609,000 after buying an additional 183,900 shares in the last quarter.

Amrize Company Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.